FDA Panel Rejects Broad Pfizer Booster Jabs Scuttling Biden's Plan, Endorses Some Shots For Elderly.

By TYler Durden: Article

"Update (1620ET): Minutes after the FDA advisory panel rejected the Biden Administration's plan to dole out booster shots to patients as young as 16, the same panel returned and voted unanimously to temporarily approve Pfizer Booster jabs for patients who are either a.) 65 or older, b.) immunocompromised or c.) both."